Frank Weinz: Arjo is Focussing on Strategies for Preventing DVT and PE
Frank Weinz, DVT Spezialist at Arjo, reposted from RPTH Journal on LinkedIn:
”Very important information about the risks for getting thrombosis, developing from orthopedic surgeries.
Arjo is focussing on strategies for preventing DVT and PE.
With the Flowtron ACS900, HCW‘s are having an effective and evidence prooved device for DVT prevention.”
Quoting RPTH Journal‘s post:
”We often assume VTE risk after major orthopedic surgery quickly returns to baseline.
This commentary from Charlotte Story, Lauren Merz and Jordan Schaefer takes a closer look at longer-term risk, current definitions, and what they may miss when we focus only on the early postoperative period.”
Read the full review in RPTH.
Article: Rethinking venous thromboembolism risk after major orthopedic surgery: a transient threat or a persistent problem?
Authors: Charlotte Story, Lauren E. Merz, Jordan K. Schaefer
Stay updated on all scientific advances with Hemostasis Today.
-
May 29, 2026, 13:49Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk